7Falls D L. Neuregulins: functions, forms, and signaling strategies [J]. Exp Cell Res, 2003,284(1) :14 -30. 被引量：1
8Burden S, Yarden Y. Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis [J ]. Neuron, 1997,18:847 - 855. 被引量：1
9Cote G M, Miller T A, Lebrasseur N K, et al. Neuregulin-1 alpha and beta isoform expression in cardiac microvascular endothelial ceils and function in cardiac myocytes in vitro [ J ]. Exp-Cell-Res, 2005, 311(1) :135 -146. 被引量：1
10Lemmens K, Doggen K, De Keulenaer G W . Role of neuregulin-1/ ErbB signaling in cardiovascular physiology, and disease : implications for therapy of heart failure [ J ]. Circulation, 2007,116 ( 8 ): 954 - 960. 被引量：1
1KARIA P S, JAMBUSARIA-PAHLAJANI A, HARRING- TON D P, et al. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma[J]. J Clin Oncol, 2014,32(4):327-334. 被引量：1
2ROSS A S, WHALEN F M, ELENITSAS R, et al. Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study[J]. Dermatoi Surg, 2009,35 (12) 1859-1866. 被引量：1
3LIU L S, COLEGIO O R. Molecularly targeted therapies for nonmelanoma skin cancers[J]. Int J Derrnatol, 2013,52 (6) : 654-665. 被引量：1
4BRANTSCH K D, MEISNER C, SCHONFISCH B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study[J]. Lancet On- col, 2008,9(8) :713-720. 被引量：1
5SMITH K J, HAMZA S, SKELTON H. Histologic features in primary cutaneous squamous cell carcinomas in immuno- compromised patients focusing on organ transplant patients [J]. Dermatol Surg, 2004,30(4 Pt 2):634-641. 被引量：1
6MARTORELL-CALATAYUD A, SANMARTIN JIMENEZ O, CRUZ MOJARRIETA J, et al. Cutaneous squamous cell carcinoma: defining the high-risk variant[J]. Actas Dermosi- filiogr, 2013,104(5) : 367-379. 被引量：1
7ROWE D E, CARROLL R J, DAY C L, et al. Prognostic fac- tors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection[J]. J Am Acad Dermatol, 1992,26(6) :976-990. 被引量：1
8O'BRYAN K, SHERMAN W, NIEDT G W, et al. An evol- ving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma[J]. J Am Acad Dermatol, 2013,69 (4) : 595-602. 被引量：1
9YOON D Y, HWANG H S, CHANG S K, et al. CT, MR, US,18F-FDG PET/CT, and their combined use for the as- sessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck[J]. Eur Radiol, 2009,19(3): 634-642. 被引量：1
10JAMBUSARIA-PAHLAJANI A, HESS S D, KATZ K A, et al. Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mobs surgeons[J]. Arch Dermatol, 2010,146(11) :1225-1231. 被引量：1
